[
  {
    "ts": null,
    "headline": "Top 50 High-Quality Dividend Growth Stocks For December 2025",
    "summary": "See here for an analysis of 50 high-quality dividend growth stocks to identify timely, attractive investment opportunities.",
    "url": "https://finnhub.io/api/news?id=60576fb19e04759e332f80d617375cb7bf9abec445f08aafadc198ce3e09591f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765227824,
      "headline": "Top 50 High-Quality Dividend Growth Stocks For December 2025",
      "id": 137735866,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2242367752/image_2242367752.jpg?io=getty-c-w1536",
      "related": "RMD",
      "source": "SeekingAlpha",
      "summary": "See here for an analysis of 50 high-quality dividend growth stocks to identify timely, attractive investment opportunities.",
      "url": "https://finnhub.io/api/news?id=60576fb19e04759e332f80d617375cb7bf9abec445f08aafadc198ce3e09591f"
    }
  },
  {
    "ts": null,
    "headline": "Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy",
    "summary": "Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapySAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has received U.S. Food and Drug Administration (FDA) clearance for Personalized Therapy Comfort Settings (PTCS), to be marketed as Smart Comfort. Smart Comfort is the first FDA-cleared AI-enab",
    "url": "https://finnhub.io/api/news?id=01dc145d0f77c12c9f8ed2f8f653be211d8f64e6ba3742697d07afbde7c9c38a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765202400,
      "headline": "Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy",
      "id": 137732771,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapySAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has received U.S. Food and Drug Administration (FDA) clearance for Personalized Therapy Comfort Settings (PTCS), to be marketed as Smart Comfort. Smart Comfort is the first FDA-cleared AI-enab",
      "url": "https://finnhub.io/api/news?id=01dc145d0f77c12c9f8ed2f8f653be211d8f64e6ba3742697d07afbde7c9c38a"
    }
  },
  {
    "ts": null,
    "headline": "Is ResMed Stock Underperforming the S&P 500?",
    "summary": "Though ResMed has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=1325b7601bfd979ce30d02c2e71eeb523d55a69cbb7f55a27173202a3f5b9db3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765202294,
      "headline": "Is ResMed Stock Underperforming the S&P 500?",
      "id": 137732772,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Though ResMed has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=1325b7601bfd979ce30d02c2e71eeb523d55a69cbb7f55a27173202a3f5b9db3"
    }
  }
]